IL166343A0 - Igg fc/hiv-gp 120/c3d fusion protein - Google Patents

Igg fc/hiv-gp 120/c3d fusion protein

Info

Publication number
IL166343A0
IL166343A0 IL16634305A IL16634305A IL166343A0 IL 166343 A0 IL166343 A0 IL 166343A0 IL 16634305 A IL16634305 A IL 16634305A IL 16634305 A IL16634305 A IL 16634305A IL 166343 A0 IL166343 A0 IL 166343A0
Authority
IL
Israel
Prior art keywords
hiv
igg
fusion protein
fusion
protein
Prior art date
Application number
IL16634305A
Other languages
English (en)
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of IL166343A0 publication Critical patent/IL166343A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16634305A 2002-07-23 2005-01-17 Igg fc/hiv-gp 120/c3d fusion protein IL166343A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39760502P 2002-07-23 2002-07-23
PCT/US2003/022917 WO2004009785A2 (fr) 2002-07-23 2003-07-23 Proteine de fusion igg fc/hiv-gp120/c3d

Publications (1)

Publication Number Publication Date
IL166343A0 true IL166343A0 (en) 2006-01-16

Family

ID=30771086

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16634305A IL166343A0 (en) 2002-07-23 2005-01-17 Igg fc/hiv-gp 120/c3d fusion protein

Country Status (13)

Country Link
US (1) US20060014148A1 (fr)
EP (2) EP1523492A4 (fr)
JP (2) JP2006509496A (fr)
KR (1) KR20050036960A (fr)
CN (1) CN100366631C (fr)
AU (1) AU2003256671B2 (fr)
BR (1) BR0312808A (fr)
CA (1) CA2493706A1 (fr)
IL (1) IL166343A0 (fr)
MX (1) MXPA05000874A (fr)
NZ (1) NZ537345A (fr)
WO (1) WO2004009785A2 (fr)
ZA (1) ZA200410324B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982086B2 (en) 2000-02-04 2006-01-03 Duke University Human immunodeficiency virus immunogenic composition
US7033593B2 (en) 2000-09-22 2006-04-25 Duke University Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
JP2004511444A (ja) 2000-09-22 2004-04-15 デューク・ユニバーシティー 免疫原
US7172761B2 (en) 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7195768B2 (en) 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
AU2002363436A1 (en) 2001-11-07 2003-05-19 Duke University Polyvalent immunogen of hiv
GB0614780D0 (en) * 2006-07-25 2006-09-06 Ucb Sa Biological products
WO2009137632A2 (fr) * 2008-05-06 2009-11-12 Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Immunogène du vih et son procédé de fabrication et d'utilisation
EP2334329A1 (fr) * 2008-10-16 2011-06-22 New York Blood Center Vaccins oligomères contre le vih liés à un stimulateur d'immunité
WO2011044158A1 (fr) * 2009-10-09 2011-04-14 New York Blood Center, Inc. Compositions contre la grippe immunogènes, oligomériques, avec liaison à un immunopotentialisateur
WO2011126576A2 (fr) * 2010-04-09 2011-10-13 Duke University Signatures génétiques présentes dans la glycoprotéine d'enveloppe du vih-1
US20130069270A1 (en) 2010-05-24 2013-03-21 Pokka Corporation Granulating method and granulating device
EP2758072A1 (fr) * 2011-09-23 2014-07-30 University Of Oslo Vaccicorps dirigés contre des cellules dendritiques à présentation croisée
EP2706356A1 (fr) * 2012-09-06 2014-03-12 Laboratorios Del. Dr. Esteve, S.A. Procédés d'identification d'anticorps neutralisant le VIH
EP3662930A1 (fr) * 2015-09-24 2020-06-10 AbVitro LLC Compositions d'anticorps anti-vih et méthodes d'utilisation
AR114560A1 (es) * 2017-11-17 2020-09-23 Grifols Diagnostic Solutions Inc Proteínas antigénicas de la envoltura del virus de inmunodeficiencia humano expresadas en mamíferos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
EP0699077B1 (fr) * 1993-05-07 2001-10-31 Akzo Nobel N.V. Complexes immunogenes de v.i.h.
JP2004511444A (ja) 2000-09-22 2004-04-15 デューク・ユニバーシティー 免疫原
AU2002363436A1 (en) 2001-11-07 2003-05-19 Duke University Polyvalent immunogen of hiv

Also Published As

Publication number Publication date
CN100366631C (zh) 2008-02-06
CN1668633A (zh) 2005-09-14
WO2004009785A3 (fr) 2004-08-05
AU2003256671B2 (en) 2008-10-16
ZA200410324B (en) 2006-07-26
EP2374811A1 (fr) 2011-10-12
US20060014148A1 (en) 2006-01-19
EP1523492A4 (fr) 2006-05-10
KR20050036960A (ko) 2005-04-20
NZ537345A (en) 2007-12-21
EP1523492A2 (fr) 2005-04-20
WO2004009785A2 (fr) 2004-01-29
BR0312808A (pt) 2005-04-19
JP2010057490A (ja) 2010-03-18
AU2003256671A1 (en) 2004-02-09
MXPA05000874A (es) 2005-03-23
JP2006509496A (ja) 2006-03-23
CA2493706A1 (fr) 2004-01-29

Similar Documents

Publication Publication Date Title
IL166343A0 (en) Igg fc/hiv-gp 120/c3d fusion protein
IL166751A0 (en) Modified transferin-antibody fusion proteins
AU2002364586A8 (en) Albumin fusion proteins
AU2002364587A8 (en) Albumin fusion proteins
EP1594530A4 (fr) Proteines hybrides d'albumine
AU2003259294A1 (en) Humanized antibodies against human 4-1bb
PL362324A1 (en) Artificial fusion proteins with reduced immunogenicity
IL202255A0 (en) Binding domain-immunoglobulin fusion proteins
EP1448588A4 (fr) Anticorps et multimeres de proteines psma
AU2002307255A1 (en) Vegf fusion proteins
AU2003239365A8 (en) Recombinant glycosyltransferase fusion proteins
ZA200308589B (en) Recombinant fusion proteins and the trimers thereof.
AU2003228364A8 (en) Field-assisted fusion bonding
AU2002332041A1 (en) Albumin fusion proteins
AU2003253621A1 (en) Modified "s" antibodies
HUP0402496A3 (en) Growth hormone fusion protein
AU2002361390A1 (en) Anti-cd7 immunotoxin as fusion protein
GB9913437D0 (en) Fusion proteins
AU2002257088A1 (en) Immunoglobulin superfamily proteins
AUPR546801A0 (en) Recombinant antibodies
AU2002357891A8 (en) Dtat fusion toxin
EP1572092A3 (fr) Proteines interactives avec mk2
GB0200689D0 (en) Fusion proteins
AU2002361963A8 (en) Fusion proteins containing tlp peptides
GB0213760D0 (en) A fusion protein